Get the Stockscreener App
647.09
0.01%
0.06
After Hours:
647.09
Idexx Laboratories Inc stock is traded at $647.09, with a volume of 304.95K.
It is up +0.01% in the last 24 hours and up +12.92% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$647.03
Open:
$647.95
24h Volume:
304.95K
Relative Volume:
0.53
Market Cap:
$51.77B
Revenue:
$4.04B
Net Income/Loss:
$985.66M
P/E Ratio:
53.88
EPS:
12.01
Net Cash Flow:
$774.34M
1W Performance:
+0.24%
1M Performance:
+12.92%
6M Performance:
+46.72%
1Y Performance:
+32.80%
1-Day Range:
$642.29
$652.00
1-Week Range:
$636.00
$652.00
52-Week Range:
$356.14
$688.12
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Relative strength of IDEXX Laboratories Inc. in sector analysis2025 Technical Patterns & Weekly Return Optimization Plans - Newser
Short interest data insights for IDEXX Laboratories Inc.Earnings Overview Report & Expert Verified Movement Alerts - Newser
Is IDEXX Laboratories Inc. reversing from oversold territoryJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Exit strategy if you’re trapped in IDEXX Laboratories Inc.2025 Dividend Review & Short-Term High Return Ideas - Newser
Ranking IDEXX Laboratories Inc. among high performing stocks via tools2025 Market Sentiment & Daily Market Momentum Tracking - Newser
Long term hold vs stop loss in IDEXX Laboratories Inc.Weekly Trade Analysis & Verified Swing Trading Watchlists - Newser
What indicators show strength in IDEXX Laboratories Inc.July 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
Volume spikes in IDEXX Laboratories Inc. stock – what they mean2025 Macro Impact & Weekly Chart Analysis and Guides - Newser
Risk adjusted return profile for IDEXX Laboratories Inc. analyzed2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser
Is There Enough Volume to Lift IDEXX Laboratories Inc.Quarterly Earnings Report & Comprehensive Market Scan Reports - beatles.ru
IDEXX Laboratories Inc. stock chart pattern explained2025 Top Decliners & Weekly Return Optimization Plans - Newser
Signal strength of IDEXX Laboratories Inc. stock in tech scannersPortfolio Gains Summary & Low Risk High Win Rate Picks - Newser
What to expect from IDEXX Laboratories Inc. in the next 30 daysBull Run & Safe Capital Growth Stock Tips - Newser
Has IDEXX Laboratories Inc. formed a bullish divergenceWatch List & Stepwise Entry and Exit Trade Signals - Newser
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Makes An Interesting Case - 富途牛牛
Using R and stats models for IDEXX Laboratories Inc. forecastingJobs Report & Risk Controlled Swing Alerts - Newser
What high frequency data says about IDEXX Laboratories Inc.Watch List & Growth Focused Entry Point Reports - Newser
Applying Elliott Wave Theory to IDEXX Laboratories Inc.Market Performance Recap & Advanced Technical Signal Analysis - Newser
How hedge fund analytics apply to IDEXX Laboratories Inc. stockJuly 2025 Catalysts & Low Risk Growth Stock Ideas - Newser
IDEXX Laboratories Inc. stock daily chart insightsTrade Ideas & Weekly Top Gainers Trade List - Newser
Analyzing IDEXX Laboratories Inc. with risk reward ratio chartsRisk Management & Weekly Chart Analysis and Trade Guides - Newser
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average - Zacks Investment Research
What’s the recovery path for long term holders of IDEXX Laboratories Inc.2025 Market WrapUp & Stock Timing and Entry Methods - Newser
What is the long term forecast for IDEXX Laboratories Inc. stockBond Market & Real-Time Volume Analysis Alerts - sundaytimes.kr
Using Bollinger Bands to evaluate IDEXX Laboratories Inc.Portfolio Value Report & Weekly Hot Stock Watchlists - Newser
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):